Bank Regulatory Reviews: Action Needed to Better Identify and Address Unnecessary or Unduly Burdensome Requirements

GAO reports that under EGRPRA, federal banking agencies’ decennial regulatory reviews have unclear outcomes—agencies often lack documented procedures to identify outdated rules or determine whether issues raised warrant action, and six of eight groups interviewed said reviews rarely lead to modifications or eliminations. GAO also finds agencies’ review processes lack certain leading practices, including prioritizing rules for analysis and performing cost-benefit and combined-burden assessments. The third EGRPRA review is ongoing as of July 2026, but the findings suggest limited near-term impact on regulatory burden reductions.

Analysis

This reads as a negative on the deregulation optionality that has been embedded in small- and mid-cap banks, but the real signal is that the process is mostly theater unless it is tied to a specific rulemaking docket. That matters because bank multiples can re-rate on the expectation of lower compliance expense, lower legal reserve risk, or faster capital return; this report implies those benefits are unlikely to arrive through the decennial review itself. In the near term, that caps upside for KRE and other regional-bank proxies more than for money-center names, which already trade on earnings power and funding advantage rather than regulatory relief.

The second-order effect is competitive: if fixed regulatory burden remains sticky, scale wins. JPM, BAC, and WFC can absorb documentation and model risk better than community banks, so persistent process friction is actually a quiet moat for the largest franchises and a drag on smaller banks’ ROE. For lenders with thin efficiency ratios, any incremental compliance burden can keep expense leverage high and delay multiple expansion even if credit stays benign.

Contrarian view: the market may be overestimating how much downside this report creates because the sector was never going to get broad-based relief from a GAO critique alone. The actionable catalyst is not the review, but whether the agencies publish a prioritized, quantified rollback list over the next 1-3 months; absent that, this is more of a sentiment headwind than a fundamental earnings event. If we do get a concrete package, the move should show up first in small-bank beta, not in the majors.

Key Decisions for Investors

• Fade any bank-rally tied to 'regulatory reform' headlines: short KRE vs long XLF for 1-3 months; thesis is that relief expectations are too high while compliance burden stays sticky. Falsifier: a specific agency proposal that cuts recurring bank operating costs or capital requirements.
• Overweight JPM/BAC relative to regional banks on a 6-18 month horizon; if burden stays unchanged, scale players keep a structural cost advantage and can take share without paying for it. Falsifier: broad, enforceable burden reduction that materially improves ROE for community/regional banks.
• Avoid making this a standalone bearish bank trade unless paired with a separate credit or rate view; the report is low-impact and likely not enough to move fundamentals on its own. Watch for price action only if KRE underperforms XLF by >2% on the announcement.
• Set a watch item for the next 1-3 months: if the agencies publish a prioritized list with quantified cost-benefit work, reassess regional-bank longs; absent that, treat any selloff as noise rather than a trend change.